Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is a Nervous System?01:25

What is a Nervous System?

104.3K
Overview
104.3K
Review and Preview01:10

Review and Preview

8.3K
In statistics, several tools are used to interpret the data. Measures of central tendency represent the characteristics of the data, such as mean, median, and mode. Additionally, measures of variance like standard deviation and range are used to find the spread of data from the mean. Relative standing measures the distance between data locations. Commonly used measures of relative standings are percentile, z score, and quartiles.
Percentiles are a type of fractile that partition data into...
8.3K
Review and Preview01:13

Review and Preview

10.9K
Data are individual items of information obtained from a population or sample. Data may be classified as qualitative (categorical), quantitative continuous, or quantitative discrete. Because it is not practical to measure the entire population in a study, researchers use samples to represent the population. A random sample is a representative group from the population chosen by using a method that gives each individual in the population an equal chance of being included in the sample. Random...
10.9K
The Parasympathetic Nervous System01:14

The Parasympathetic Nervous System

115.1K
Overview
115.1K
The Sympathetic Nervous System01:25

The Sympathetic Nervous System

103.1K
Overview
103.1K
The Central Dogma01:25

The Central Dogma

139.0K
Overview
139.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunity Gone Viral: Subacute Cognitive Decline With Multifocal Brain Lesions in Neuromyelitis Optica Spectrum Disorder.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Nearest-neighbors assisted unsupervised analysis for methylation array profiling for central nervous system tumors.

Brain pathology (Zurich, Switzerland)·2026
Same author

Deep learning for H&E-based meningioma molecular classification and outcome prediction: a retrospective cohort study.

The Lancet. Digital health·2026
Same author

Inside the Heterogeneity of Primary CNS Vasculitis: A Single-Center 40-Year Experience.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Chromosome-arm-specific telomere length governs dual modes of structural genome evolution in IDH-mutant astrocytoma.

bioRxiv : the preprint server for biology·2026
Same author

Comparison of clinical, radiographic and genomic alterations between histologic and molecular glioblastoma, <i>IDH</i>-wildtype.

Neuro-oncology advances·2026

Related Experiment Video

Updated: Jan 21, 2026

Optical Clearing of the Mouse Central Nervous System Using Passive CLARITY
10:28

Optical Clearing of the Mouse Central Nervous System Using Passive CLARITY

Published on: June 30, 2016

14.0K

Case-based review: primary central nervous system lymphoma.

Agnieszka Korfel1, Uwe Schlegel2, Derek R Johnson3

  • 1Department of Hematology, Oncology and Tumor Immunology, Charite University Medicine, Berlin, Germany (A.K.).

Neuro-Oncology Practice
|August 7, 2019
PubMed
Summary
This summary is machine-generated.

Primary CNS lymphoma (PCNSL) is a rare brain cancer. Current treatment focuses on high-dose methotrexate chemotherapy, avoiding whole-brain radiotherapy due to toxicity risks.

Keywords:
high-dose methotrexateneurotoxicityprimary CNS lymphomawhole-brain radiotherapy

More Related Videos

Culturing Microglia from the Neonatal and Adult Central Nervous System
11:28

Culturing Microglia from the Neonatal and Adult Central Nervous System

Published on: August 9, 2013

28.8K
Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
14:55

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

Published on: May 12, 2013

61.8K

Related Experiment Videos

Last Updated: Jan 21, 2026

Optical Clearing of the Mouse Central Nervous System Using Passive CLARITY
10:28

Optical Clearing of the Mouse Central Nervous System Using Passive CLARITY

Published on: June 30, 2016

14.0K
Culturing Microglia from the Neonatal and Adult Central Nervous System
11:28

Culturing Microglia from the Neonatal and Adult Central Nervous System

Published on: August 9, 2013

28.8K
Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
14:55

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

Published on: May 12, 2013

61.8K

Area of Science:

  • Neuro-oncology
  • Hematology
  • Immunology

Background:

  • Primary CNS lymphoma (PCNSL) is a rare B-cell malignancy confined to the central nervous system.
  • PCNSL incidence is increasing, especially in older adults, with immunosuppression as a risk factor, though most patients are immunocompetent.
  • Diagnosis can be challenging, often requiring tumor biopsy despite potential utility of non-invasive tests.

Purpose of the Study:

  • To review the current understanding and management of Primary CNS Lymphoma.
  • To highlight diagnostic challenges and treatment strategies for PCNSL.
  • To discuss ongoing research addressing optimal PCNSL treatment.

Main Methods:

  • Literature review of primary CNS lymphoma diagnosis and treatment.
  • Analysis of current treatment protocols, including chemotherapy and radiotherapy.
  • Discussion of results from clinical trials and ongoing research.

Main Results:

  • High-dose methotrexate-based chemotherapy is the current standard initial treatment for PCNSL.
  • Whole-brain radiotherapy at standard doses does not improve survival and increases neurological toxicity.
  • Ongoing trials explore reduced-dose radiotherapy, rituximab, high-dose chemotherapy with stem cell transplant, and maintenance therapy.

Conclusions:

  • Optimal treatment for PCNSL remains under investigation due to limited trial data.
  • Current management prioritizes methotrexate chemotherapy, balancing efficacy with reduced neurological side effects.
  • Future research aims to refine treatment strategies, incorporating novel agents and approaches for improved outcomes.